Exscientia PLC has a consensus price target of $10.8 based on the ratings of 6 analysts. The high is $20 issued by Goldman Sachs on May 24, 2022. The low is $5 issued by Barclays on August 13, 2024. The 3 most-recent analyst ratings were released by Barclays, Barclays, and Morgan Stanley on August 13, 2024, July 29, 2024, and April 22, 2024, respectively. With an average price target of $7 between Barclays, Barclays, and Morgan Stanley, there's an implied 40.28% upside for Exscientia PLC from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Exscientia (NASDAQ:EXAI) was reported by Barclays on August 13, 2024. The analyst firm set a price target for $5.00 expecting EXAI to rise to within 12 months (a possible 0.20% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Exscientia (NASDAQ:EXAI) was provided by Barclays, and Exscientia downgraded their equal-weight rating.
There is no last upgrade for Exscientia
The last downgrade for Exscientia PLC happened on August 13, 2024 when Barclays changed their price target from N/A to $5 for Exscientia PLC.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exscientia, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exscientia was filed on August 13, 2024 so you should expect the next rating to be made available sometime around August 13, 2025.
While ratings are subjective and will change, the latest Exscientia (EXAI) rating was a downgraded with a price target of $0.00 to $5.00. The current price Exscientia (EXAI) is trading at is $4.99, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.